Crosstalk Between N6-Methyladenosine and Other Epigenetic Mechanisms in Central Nervous System Development and Disorders
Biomolecules · 28.07.2025 · 15 (8) · 1092
DOI: 10.3390/biom15081092 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 28.07.2025. Verfasst von Cuiping Qi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, China. Hauptthemen laut MEDLINE: Adenosine, Epigenesis, Genetic, Central Nervous System, Central Nervous System Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Outstanding Young Scholar Foundation of Hubei Province.
Abstract (Originalsprache)
A variety of epigenetic mechanisms—such as DNA methylation, histone alterations, RNA chemical modifications, and regulatory non-coding RNAs—collectively influence gene regulation and cellular processes. Among these, N6-methyladenosine (m6A) represents the most widespread internal modification in eukaryotic mRNA, exerting significant influence on RNA metabolic pathways and modulating mRNA function at multiple levels. Studies have shown that m6A modification is highly enriched in the brain and regulates central nervous system development and various physiological functions. Recent studies have demonstrated that m6A interacts with other epigenetic regulators and triggers epigenetic remodeling, which further affects the development and occurrence of central nervous system diseases. In this review, we provide an up-to-date overview of this emerging research hotspot in biology, with a focus on the interplay between m6A and other epigenetic regulators. We highlight their potential roles and regulatory mechanisms in epigenetic reprogramming during central nervous system development and disease, offering insights into potential novel targets and therapeutic strategies for CNS disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, China.
- Department of Pharmacology, Taikang Medical School (School of Basic Medical Sciences), Wuhan University, Wuhan 430071, China.
- Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan 430071, China.
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Outstanding Young Scholar Foundation of Hubei Province
Zitieren
APA
Qi, C., Jin, X., Wang, H., & Xu, D. (2025). Crosstalk Between N6-Methyladenosine and Other Epigenetic Mechanisms in Central Nervous System Development and Disorders. Biomolecules, 15(8), 1092. https://doi.org/10.3390/biom15081092
Vancouver
Qi C, Jin X, Wang H, Xu D. Crosstalk Between N6-Methyladenosine and Other Epigenetic Mechanisms in Central Nervous System Development and Disorders. Biomolecules. 2025;15(8):1092. doi:10.3390/biom15081092
BibTeX
@article{Qi2025,
author = {Qi, Cuiping and Jin, Xiuping and Wang, Hui and Xu, Dan},
title = {Crosstalk Between N6-Methyladenosine and Other Epigenetic Mechanisms in Central Nervous System Development and Disorders},
journal = {Biomolecules},
year = {2025},
volume = {15},
number = {8},
pages = {1092},
doi = {10.3390/biom15081092}
}
EUVIMED